The increased presence of the mapA gene in Lactobacillus isolates derived from our healthy individuals in comparison with IBD patients, as well as the same observation in patients with controlled disease in comparison with active disease, support the role of mapA gene in increasing the effect of probiotic Lactobacillus on the regulation of the immune response inside GI tract. The gene discussed is LRRC25; the disease is inflammatory bowel disease.